Skip to main content
Erschienen in: Annals of Surgical Oncology 6/2016

19.01.2016 | Colorectal Cancer

Colorectal Cancer Resections in the Oldest Old Between 2011 and 2012 in The Netherlands

verfasst von: N. M. Verweij, MD, A. H. W. Schiphorst, MD, PhD, H. A. Maas, MD, PhD, D. D. E. Zimmerman, MD, PhD, FEBS, F. van den Bos, MD, A. Pronk, MD, PhD, FEBS, I. H. M. Borel Rinkes, Prof, MD, PhD, M. E. Hamaker, MD, PhD

Erschienen in: Annals of Surgical Oncology | Ausgabe 6/2016

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Adequate decision-making in elderly colorectal cancer patients requires accurate information regarding risks of treatment. We analysed the outcome and survival of colorectal resections in the oldest old (≥85 years).

Methods

An analysis of the 2011–2012 data from two large nationwide registries: the Dutch Surgical Colorectal Audit (DSCA), containing all colorectal cancer resections, and the Netherlands Cancer Registry (NCR), containing survival data for all newly diagnosed malignancies.

Results

The study included more than 1200 patients aged ≥85 years (DSCA n = 1232, NCR n = 1206). The postoperative complication rate was 41 % in the oldest old. The frequency of cardiopulmonary complications rose rapidly with age, from 11 % in those <70 years to 38 % for the oldest old (p < 0.001). Postoperative 30-day mortality rate was 10 % in the oldest old. Three-month mortality was 14 % (compared with 3 % of patients <85 years; p < 0.001). One-year mortality was 24 % and 2-year mortality 36 %. After correction for expected mortality in the general population, excess mortality for the oldest old was 12 % in the first year and 3 % in the second year.

Conclusions

In this study of more than 1200 colorectal cancer patients aged ≥85 years undergoing surgical resection, we found high rates of cardiopulmonary complications and excess mortality, particularly in the first year after surgery. We propose that these data could be incorporated into individualized treatment algorithms, which also include detailed information regarding the patients’ health status.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Coleman MP, Quaresma M, Berrino F, et al. Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol. 2008;9:730–56.CrossRefPubMed Coleman MP, Quaresma M, Berrino F, et al. Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol. 2008;9:730–56.CrossRefPubMed
3.
Zurück zum Zitat Jemal A, Bray F, Center MM, et al. Global cancer statistics. Cancer J Clin. 2011;61:69–90.CrossRef Jemal A, Bray F, Center MM, et al. Global cancer statistics. Cancer J Clin. 2011;61:69–90.CrossRef
4.
Zurück zum Zitat Active early detection colon cancer programs: ‘Rijksinstituut voor Volksgezondheid en Milieu’, bevolkingsonderzoek darmkanker. www.RIVM.nl. Accessed 1 Feb 2015. Active early detection colon cancer programs: ‘Rijksinstituut voor Volksgezondheid en Milieu’, bevolkingsonderzoek darmkanker. www.​RIVM.​nl. Accessed 1 Feb 2015.
6.
Zurück zum Zitat Hewitson P, Glasziou PP, Irwig L, Towler B, Watson E. Screening for colorectal cancer using the faecal occult blood test, hemoccult. Cochrane Database Syst Rev. 2007;24(1):CD001216. Hewitson P, Glasziou PP, Irwig L, Towler B, Watson E. Screening for colorectal cancer using the faecal occult blood test, hemoccult. Cochrane Database Syst Rev. 2007;24(1):CD001216.
7.
Zurück zum Zitat Verweij NM, Schiphorst AHW, Pronk A, Hamaker ME. Conventional and laparoscopic colon resections in the elderly. World J Colorectal Surg. 2015;5(2):3. Verweij NM, Schiphorst AHW, Pronk A, Hamaker ME. Conventional and laparoscopic colon resections in the elderly. World J Colorectal Surg. 2015;5(2):3.
8.
Zurück zum Zitat Extermann M, Aapro M, Bernabei R, et al. Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). Crit Rev Oncol Hematol. 2005;55(3):241–52.CrossRefPubMed Extermann M, Aapro M, Bernabei R, et al. Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). Crit Rev Oncol Hematol. 2005;55(3):241–52.CrossRefPubMed
9.
Zurück zum Zitat Hamaker ME, Acampo T, Remijn JA, et al. Diagnostic choices and clinical outcomes in octogenarians and nonagenarians with iron-deficiency anemia in the Netherlands. J Am Geriatr Soc. 2013;61(4):495–501.CrossRefPubMed Hamaker ME, Acampo T, Remijn JA, et al. Diagnostic choices and clinical outcomes in octogenarians and nonagenarians with iron-deficiency anemia in the Netherlands. J Am Geriatr Soc. 2013;61(4):495–501.CrossRefPubMed
10.
Zurück zum Zitat Lewis JH, Kilgore ML, Goldman DP, et al. Participation of patients 65 years of age or older in cancer clinical trials. J Clin Oncol. 2003;21(7):1383–9.CrossRefPubMed Lewis JH, Kilgore ML, Goldman DP, et al. Participation of patients 65 years of age or older in cancer clinical trials. J Clin Oncol. 2003;21(7):1383–9.CrossRefPubMed
11.
Zurück zum Zitat Zulman DM, Sussman JB, Chen X, et al. Examining the evidence: a systematic review of the inclusion and analysis of older adults in randomized controlled trials. J Gen Intern Med. 2011;26(7):783–90.CrossRefPubMedPubMedCentral Zulman DM, Sussman JB, Chen X, et al. Examining the evidence: a systematic review of the inclusion and analysis of older adults in randomized controlled trials. J Gen Intern Med. 2011;26(7):783–90.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Schiphorst AH, Pronk A, Borel Rinkes IH, Hamaker ME. Representation of the elderly in trials of laparoscopic surgery for colorectal cancer. Colorectal Dis. 2014;16(12):976–83.CrossRefPubMed Schiphorst AH, Pronk A, Borel Rinkes IH, Hamaker ME. Representation of the elderly in trials of laparoscopic surgery for colorectal cancer. Colorectal Dis. 2014;16(12):976–83.CrossRefPubMed
13.
Zurück zum Zitat Van Leersum NJ, Snijders HS, Henneman D, et al. The Dutch surgical colorectal audit. Eur J Surg Oncol. 2013;39(10):1063–70.CrossRefPubMed Van Leersum NJ, Snijders HS, Henneman D, et al. The Dutch surgical colorectal audit. Eur J Surg Oncol. 2013;39(10):1063–70.CrossRefPubMed
15.
Zurück zum Zitat Hackett NJ, De Oliveira GS, Jain UK, Kim JY. ASA class is a reliable independent predictor of medical complications and mortality following surgery. Int J Surg. 2015;18:184–90.CrossRefPubMed Hackett NJ, De Oliveira GS, Jain UK, Kim JY. ASA class is a reliable independent predictor of medical complications and mortality following surgery. Int J Surg. 2015;18:184–90.CrossRefPubMed
17.
Zurück zum Zitat Dekker JW, van den Broek CB, Bastiaannet E, et al. Importance of the first postoperative year in the prognosis of elderly colorectal cancer patients. Ann Surg Oncol. 2011;18(6):1533–9.CrossRefPubMedPubMedCentral Dekker JW, van den Broek CB, Bastiaannet E, et al. Importance of the first postoperative year in the prognosis of elderly colorectal cancer patients. Ann Surg Oncol. 2011;18(6):1533–9.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Schiphorst AHW, Verweij NM, Pronk A, Hamaker ME. Age-related guideline adherence and outcome in low rectal cancer. Dis Colon Rectum. 2014;57:967–75.CrossRefPubMed Schiphorst AHW, Verweij NM, Pronk A, Hamaker ME. Age-related guideline adherence and outcome in low rectal cancer. Dis Colon Rectum. 2014;57:967–75.CrossRefPubMed
19.
Zurück zum Zitat Gooiker GA, Dekker JW, Bastiaannet E, et al. Risk factors for excess mortality in the first year after curative surgery for colorectal cancer. Ann Surg Oncol. 2012;19:2428–34.CrossRefPubMedPubMedCentral Gooiker GA, Dekker JW, Bastiaannet E, et al. Risk factors for excess mortality in the first year after curative surgery for colorectal cancer. Ann Surg Oncol. 2012;19:2428–34.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Hamaker ME, Prins MC, Schiphorst AH, et al. Long-term changes in physical capacity after colorectal cancer treatment. J Geriatr Oncol. 2015;6(2):153–64.CrossRefPubMed Hamaker ME, Prins MC, Schiphorst AH, et al. Long-term changes in physical capacity after colorectal cancer treatment. J Geriatr Oncol. 2015;6(2):153–64.CrossRefPubMed
21.
Zurück zum Zitat Wildiers H, Heeren P, Puts M, et al. International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer. J Clin Oncol. 2014;32(24):2595–603.CrossRefPubMed Wildiers H, Heeren P, Puts M, et al. International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer. J Clin Oncol. 2014;32(24):2595–603.CrossRefPubMed
22.
Zurück zum Zitat Hamaker ME, Schiphorst AH, ten Bokkel Huinink D, Schaar C, van Munster BC. The effect of a geriatric evaluation on treatment decisions for older cancer patients-a systematic review. Acta Oncol. 2014;53(3):289–96.CrossRefPubMed Hamaker ME, Schiphorst AH, ten Bokkel Huinink D, Schaar C, van Munster BC. The effect of a geriatric evaluation on treatment decisions for older cancer patients-a systematic review. Acta Oncol. 2014;53(3):289–96.CrossRefPubMed
23.
Zurück zum Zitat Cesari M, Cerullo F, Zamboni V, Di Palma R, et al. Functional status and mortality in older women with gynecological cancer. J Gerontol A Biol Sci Med Sci. 2013;68(9):1129–33.CrossRefPubMed Cesari M, Cerullo F, Zamboni V, Di Palma R, et al. Functional status and mortality in older women with gynecological cancer. J Gerontol A Biol Sci Med Sci. 2013;68(9):1129–33.CrossRefPubMed
24.
Zurück zum Zitat Hoppe S, Rainfray M, Fonck M, Hoppenreys L, et al. Functional decline in older patients with cancer receiving first-line chemotherapy. J Clin Oncol. 2013;31(31):3877–82.CrossRefPubMed Hoppe S, Rainfray M, Fonck M, Hoppenreys L, et al. Functional decline in older patients with cancer receiving first-line chemotherapy. J Clin Oncol. 2013;31(31):3877–82.CrossRefPubMed
25.
Zurück zum Zitat Huisman MG, van Leeuwen BL, Ugolini G, Montroni I, et al. “Timed Up & Go”: a screening tool for predicting 30-day morbidity in onco-geriatric surgical patients? A multicenter cohort study. PLoS One. 2014;9(1):e86863.CrossRefPubMedPubMedCentral Huisman MG, van Leeuwen BL, Ugolini G, Montroni I, et al. “Timed Up & Go”: a screening tool for predicting 30-day morbidity in onco-geriatric surgical patients? A multicenter cohort study. PLoS One. 2014;9(1):e86863.CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Soubeyran P, Fonck M, Blanc-Bisson C, Blanc JF, et al. Predictors of early death risk in older patients treated with first-line chemotherapy for cancer. J Clin Oncol. 2012;30(15):1829–34.CrossRefPubMed Soubeyran P, Fonck M, Blanc-Bisson C, Blanc JF, et al. Predictors of early death risk in older patients treated with first-line chemotherapy for cancer. J Clin Oncol. 2012;30(15):1829–34.CrossRefPubMed
27.
Zurück zum Zitat Lee SJ, Lindquist K, Segal MR, Covinsky KE. Development and validation of a prognostic index for 4-year mortality in older adults. JAMA. 2006;295(7):801–8.CrossRefPubMed Lee SJ, Lindquist K, Segal MR, Covinsky KE. Development and validation of a prognostic index for 4-year mortality in older adults. JAMA. 2006;295(7):801–8.CrossRefPubMed
28.
Zurück zum Zitat Gillis C, Li C, Lee L, et al. Prehabilitation versus rehabilitation: a randomized control trial in patients undergoing colorectal resection for cancer. Anesthesiology. 2014;121(5):937–47.CrossRefPubMed Gillis C, Li C, Lee L, et al. Prehabilitation versus rehabilitation: a randomized control trial in patients undergoing colorectal resection for cancer. Anesthesiology. 2014;121(5):937–47.CrossRefPubMed
Metadaten
Titel
Colorectal Cancer Resections in the Oldest Old Between 2011 and 2012 in The Netherlands
verfasst von
N. M. Verweij, MD
A. H. W. Schiphorst, MD, PhD
H. A. Maas, MD, PhD
D. D. E. Zimmerman, MD, PhD, FEBS
F. van den Bos, MD
A. Pronk, MD, PhD, FEBS
I. H. M. Borel Rinkes, Prof, MD, PhD
M. E. Hamaker, MD, PhD
Publikationsdatum
19.01.2016
Verlag
Springer International Publishing
Erschienen in
Annals of Surgical Oncology / Ausgabe 6/2016
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-015-5085-z

Weitere Artikel der Ausgabe 6/2016

Annals of Surgical Oncology 6/2016 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.